US2015376627A1PendingUtilityA1
Inducible Expression System Transcription Modulators Comprising A Distributed Protein Transduction Domain And Methods For Using The Same
Est. expiryNov 24, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C07K 14/4703C12N 15/8217C07K 2319/81C12N 15/8238C12N 15/635C07K 2319/80C07K 2319/10C07K 14/4705
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Aspects of the invention include inducible expression systems in which a transcription modulator having a distributed protein transduction domain is employed. Aspects of the invention further include methods of using the systems to induce expression of a coding sequence, as well as kits that find use in practicing methods of the invention. The systems, components thereof, methods and kits find use in a variety of different applications.
Claims
exact text as granted — not AI-modified1 . An inducible expression system comprising:
(a) a host cell comprising an expression cassette comprising:
(i) a transcription modulator responsive element;
(ii) a promoter; and
(iii) a coding sequence; and
(b) a transcription modulator comprising: (i) a transcription modulator domain that binds to the transcription modulator responsive element; (ii) an expression modulatory domain operably linked to the transcription modulator domain; and
(iii) a distributed protein transduction domain.
2 . The expression system according to claim 1 , wherein the transcription modulator responsive element is a Tet responsive element.
3 . The expression system according to claim 1 , wherein the transcription modulator domain is a Tet transcription modulator domain.
4 . The expression system according to claim 3 , wherein the Tet transcription modulator binds to the transcription modulator responsive element in the absence of an expression mediator.
5 . The expression system according to claim 3 , wherein the Tet transcription modulator binds to the transcription modulator responsive element in the presence of an expression mediator.
6 . The expression system according to claim 1 , wherein the system further includes an expression mediator.
7 . The expression system according to claim 6 , wherein the expression mediator is selected from the group consisting of tetracycline and doxycycline.
8 . The expression system according to claim 1 , wherein the distributed protein transduction domain comprises a basic patch made up 3 or more non-sequential basic amino acid residues.
9 . The expression system according to claim 8 , wherein the number percentage of basic amino acid residues in the basic patch is 30 or more.
10 . The expression system according to claim 1 , wherein the expression system further comprises a transduction enhancer.
11 . The expression system according to claim 10 , wherein the transduction enhancer is a DNA transfection reagent.
12 . A transcription modulator comprising:
(i) a transcription modulator domain that binds to a transcription modulator responsive element; (ii) an expression modulatory domain fused to the transcription modulator domain; and
(iii) a distributed protein transduction domain.
13 - 17 . (canceled)
18 . A nucleic acid encoding a transcription modulator comprising:
(i) a transcription modulator domain that binds to a transcription modulator responsive element; (ii) an expression modulatory domain fused to the transcription modulator domain; and
(iii) a distributed protein transduction domain.
19 - 23 . (canceled)
24 . A method of inducing expression of a coding sequence in a host cell, the method comprising:
(a) providing a host cell comprising:
(i) an expression cassette comprising: a transcription modulator responsive element, a promoter and the coding sequence; and
(ii) a transcription modulator comprising: a transcription modulator domain that binds to the transcription modulator responsive element in an expression mediator mediated manner, an expression modulatory domain operably linked to the transcription modulator domain, and a distributed protein transduction domain; and
(b) maintaining the host cell under conditions sufficient to induce expression of the coding sequence.
25 . The method according to claim 24 , wherein the method comprises changing the concentration in the host cell of an expression mediator that mediates binding of the transcription modulator to the transcription modulator responsive element in a manner sufficient to express the coding sequence.
26 . The method according to claim 24 , wherein the transcription modulator responsive element is a Tet responsive element and the transcription modulator is a Tet regulatory domain.
27 - 29 . (canceled)
30 . The method according to claim 25 , wherein the expression mediator is selected from the group consisting of tetracycline and doxycycline.
31 . The method according to claim 24 , wherein the distributed protein transduction domain comprises a basic patch made up 3 or more non-sequential basic amino acid residues.
32 . The method according to claim 31 , wherein the number percentage of basic amino acid residues in the basic patch is 30 or more.
33 . The method according to claim 24 , wherein the method further comprises contacting the host cell with a transduction enhancer.
33 - 46 . (canceled)Join the waitlist — get patent alerts
Track US2015376627A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.